The Effect of Immunomodulatory Drugs on Aortic Stenosis: A Mendelian Randomisation Analysis - 30/07/23
Doi : 10.1016/j.hlc.2023.06.447
J. Ciofani 1, 2, 3, D. Han 4, 5, M. Nazarzadeh 6, 7, U. Allahwala 1, 2, G. De Maria 8, A. Banning 8, R. Bhindi 1, 2, K. Rahimi 6, 7, 9
1 Department of Cardiology, Royal North Shore Hospital, Sydney, NSW, Australia
2 Sydney Medical School, The University of Sydney, Sydney, NSW, Australia
3 Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK
4 Medical Research Council Laboratory of Molecular Biology, Cambridge, UK
5 Department of Physiology, Development and Neuroscience, Cambridge, UK
6 Deep Medicine, Oxford Martin School, Oxford, UK
7 Nuffield Department of Women’s and Reproductive Health, Medical Science Division, University of Oxford, Oxford, UK
8 Oxford Heart Centre, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
9 National Institute for Health Research Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
451
Le texte complet de cet article est disponible en PDF.Plan
© 2023
Publié par Elsevier Masson SAS.
Vol 32 - N° S3
P. S317 - juillet 2023 Retour au numéro
Article précédent
- The Australian Genetic Heart Disease Registry: Insights Into Health Care Utilisation and Outcomes for Genetic Heart Disease
- A. Butters, B. Blanch, A. Kemp-Casey, J. Do, F. Leslie, C. Semsarian, L. Nedkoff, T. Briffa, J. Ingles, J. Sweeting
- The Kids Heart BioBank—Supporting Patient Care and Research Into Congenital Heart Disease
- G. Blue, D. Hilton, B. O'Malley, A. Morrish, R. Harvey, S. Dunwoodie, G. Sholler, D. Winlaw
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?